Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma
about
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell linesA short Nur77-derived peptide converts Bcl-2 from a protector to a killerThe restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonistUnravelling the bcl-2 apoptosis code with a simple model system.Screening efficient BH3-mimetics to hBcl-B by means of peptidodynmimetic method.High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometry.Distinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiation.Bcl-B expression in human epithelial and nonepithelial malignancies.Dichotomous roles for the orphan nuclear receptor NURR1 in breast cancerOrphan nuclear receptor Nur77 Inhibits Oxidized LDL-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like cells.Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis.Importance of innate mucosal immunity and the promises it holds.NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells.BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients.The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell death.Bcl-2-family proteins and hematologic malignancies: history and future prospects.Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins.Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity.Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival.BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic miceTargeting the BCL-2 family in malignancies of germinal centre origin.Regulation of anti-apoptotic BCL2-proteins by non-canonical interactions: the next step forward or two steps back?Nur77: a potential therapeutic target in cancer.Relative impact of 3- and 5-hydroxyl groups of cytosporone B on cancer cell viability.Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1.Fas apoptosis inhibitory molecule regulates T cell receptor-mediated apoptosis of thymocytes by modulating Akt activation and Nur77 expression.BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia.Bcl-2 turns deadly.Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells.
P2860
Q24303516-BB56CF89-2B87-4192-ACB4-CBECAE88A676Q24319007-8997C20D-6772-4BB7-B668-A16081CC898BQ27675459-68378AB5-B0B4-4E03-B119-D1BF9C96FC42Q33344919-2B4EEE6B-A173-46B5-B97D-3984E92452DDQ33457038-8FC35C75-D6D1-44B8-8EFB-1FD5ED807489Q33895708-71435BFC-E697-4550-86BC-D58F61E643A2Q33903974-CA2B31A5-4C12-43C3-BEAA-D216E296E111Q34224114-F5F30A33-A223-46D6-8CC7-F1C96757D7A5Q34630752-BB98DD70-CB6B-4019-8C54-397875CBBCA7Q34762092-F15BDF86-BAEA-4D6D-8C47-2A86B42F7E5FQ34790083-EEBC6FD5-272D-44E5-8AC3-9DABF57F2804Q34894817-6030C2E9-96CC-4E84-A7AE-AA4161CCB6A9Q35006266-555182A1-845F-451C-B096-0C7E763A1E07Q36050710-E5295A57-5E2B-4782-B67C-87088222F3BDQ36119425-C480C319-24C0-407F-8254-B6C0C89A0642Q36508817-BE719252-7122-4283-AA01-9A494B923F04Q37065711-576C1531-08B1-4736-817D-7679BDD7A39FQ37099933-31C137BF-C50E-4BED-A6E2-0A12A1196872Q37179317-DB4CDA8E-66B1-4FAB-97FA-0E21D0F5C8B1Q37197900-A57BB880-BE80-45FD-B704-7C6BF21750BDQ37634558-F912F51B-8279-45C1-B67B-BCC9B1C6EC4FQ37928566-E0495424-C268-4095-830D-1B6D6E979A74Q38005745-FE19AFE0-CD14-4069-8052-FDA7041250E4Q39085651-B17F3E63-21F2-46A1-9192-F0BEC6CE61D0Q39646171-3B1FF85A-89B6-4BB2-AFAA-E642F1C26C18Q39982673-AE772869-40B0-4AC2-A1DD-6B489327AE37Q41470921-96C36FE9-82A3-407B-9A2D-0B01E4452A45Q42083057-6EE61BE0-C584-4FB7-942F-B6D96649E39EQ42776492-AC272FE5-615F-4B7C-8003-67BD77460892Q42814347-6E63FC09-00B0-44C5-A1EA-99C5765DEB85Q50134139-333DC21D-289A-4842-B55D-8A953AF66791Q51369579-3EE0AB10-EF44-421A-B29B-64504B84F988Q54396432-DC9B03EA-414B-45EC-B391-1B63CCC1DA73
P2860
Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nur77 converts phenotype of Bc ...... ed in plasma cells and myeloma
@ast
Nur77 converts phenotype of Bc ...... ed in plasma cells and myeloma
@en
type
label
Nur77 converts phenotype of Bc ...... ed in plasma cells and myeloma
@ast
Nur77 converts phenotype of Bc ...... ed in plasma cells and myeloma
@en
prefLabel
Nur77 converts phenotype of Bc ...... ed in plasma cells and myeloma
@ast
Nur77 converts phenotype of Bc ...... ed in plasma cells and myeloma
@en
P2093
P2860
P1433
P1476
Nur77 converts phenotype of Bc ...... ed in plasma cells and myeloma
@en
P2093
Alan Lichtenstein
Arnold C Satterthwait
Benjamin Faustin
Dayong Zhai
Jean-Marie Bruey
John C Reed
Maryla Krajewska
Paulina Ortiz-Rubio
Siva Kumar Kolluri
Stan Krajewski
P2860
P304
P356
10.1182/BLOOD-2006-11-056879
P407
P577
2007-01-16T00:00:00Z